52
Views
0
CrossRef citations to date
0
Altmetric
Clinical Research

Venomous snakebites in children: a 10 year experience in South China

, , , ORCID Icon, &
Received 29 Apr 2023, Accepted 20 Mar 2024, Published online: 26 Apr 2024

References

  • World Health Organization. Snakebite envenoming: a strategy for prevention and control. Geneva, Switzerland: World Health Organization; 2019.
  • Chippaux JP. Incidence and mortality due to snakebite in the Americas. PLoS Negl Trop Dis. 2017;11(6):e0005662. doi: 10.1371/journal.pntd.0005662.
  • Pach S, Le Geyt J, Gutierrez JM, et al. Paediatric snakebite envenoming: the world’s most neglected 'neglected tropical disease’? Arch Dis Child. 2020;105(12):1135–1139. doi: 10.1136/archdischild-2020-319417.
  • Kasturiratne A, Wickremasinghe AR, de Silva N, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):e218. doi: 10.1371/journal.pmed.0050218.
  • Gutiérrez JM, Calvete JJ, Habib AG, et al. Snakebite envenoming. Nat Rev Dis Primers. 2017;3(1):17079. doi: 10.1038/nrdp.2017.79.
  • Brenes-Chacón H, Gutiérrez JM, Camacho-Badilla K, et al. Snakebite envenoming in children: a neglected tropical disease in a costa rican paediatric tertiary care center. Acta Trop. 2019;200:105176. doi: 10.1016/j.actatropica.2019.105176.
  • Longbottom J, Shearer FM, Devine M, et al. Vulnerability to snakebite envenoming: a global mapping of hotspots. Lancet. 2018;392(10148):673–684. doi: 10.1016/S0140-6736(18)31224-8.
  • Ralph R, Sharma SK, Faiz MA, et al. The timing is right to end snakebite deaths in South Asia. BMJ. 2019;364:k5317. doi: 10.1136/bmj.k5317.
  • Chinese snakebite management consensus expert group. Expert consensus on snakebite treatment in China in 2018. Chin J Emerg Med. 2018;27:1315–1322.
  • Mong R, Ng VCH, Tse ML. Safety profile of snake antivenom (use) in Hong Kong - a review of 191 cases from 2008 to 2015. Clin Toxicol (Phila). 2017;55(10):1066–1071. doi: 10.1080/15563650.2017.1334916.
  • Chotai PN, Watlington J, Lewis S, et al. Paediatric snakebites: comparing patients in two geographic locations in the United States. J Surg Res. 2021;265:297–302. doi: 10.1016/j.jss.2021.03.045.
  • Le Geyt J, Pach S, Gutierrez JM, et al. Paediatric snakebite envenoming: recognition and management of cases. Arch Dis Child. 2021;106(1):14–19. doi: 10.1136/archdischild-2020-319428.
  • McGain F, Limbo A, Williams DJ, et al. Snakebite mortality at port moresby general hospital, Papua New Guinea, 1992-2001. Med J Aust. 2004;181(11-12):687–691. doi: 10.5694/j.1326-5377.2004.tb06525.x.
  • World Health Organization. Guidelines for the management of snakebites. 2nd ed. New Delhi, India: WHO Regional Office for South-East Asia; 2016.
  • Chippaux JP. Estimate of the burden of snakebites in Sub-Saharan Africa: a meta-analytic approach. Toxicon. 2011;57(4):586–599. doi: 10.1016/j.toxicon.2010.12.022.
  • Suraweera W, Warrell D, Whitaker R, et al. Trends in snakebite deaths in India from 2000 to 2019 in a nationally representative mortality study. Elife. 2020;9:e54076. doi: 10.7554/eLife.54076.
  • Marano M, Pisani M, Zampini G, et al. Acute exposure to European viper bite in children: advocating for a paediatric approach. Toxins (Basel). 2021;13(5):330. doi: 10.3390/toxins13050330.
  • Hon KL, Kwok LW, Leung TF. Snakebites in children in the densely populated city of Hong Kong: a 10-year survey. Acta Paediatr. 2004;93(2):270–272. doi: 10.1111/j.1651-2227.2004.tb00719.x.
  • Rathnayaka R, Ranathunga P, Kularatne SAM. Epidemiological and clinical features of hump-nosed pit viper (hypnale hypnale and hypnale zara) envenoming in children. PLoS Negl Trop Dis. 2022;16(12):e0011013. doi: 10.1371/journal.pntd.0011013.
  • Sankar J, Nabeel R, Sankar MJ, et al. Factors affecting outcome in children with snake envenomation: a prospective observational study. Arch Dis Child. 2013;98(8):596–601. doi: 10.1136/archdischild-2012-303025.
  • Karabuva S, Vrkić I, Brizić I, et al. Venomous snakebites in children in Southern Croatia. Toxicon. 2016;112:8–15. doi: 10.1016/j.toxicon.2016.01.057.
  • Tekin R, Sula B, Cakırca G, et al. Comparison of snakebite cases in children and adults. Eur Rev Med Pharmacol. 2015;19:2711–2716.
  • Levine M, Ruha AM, Wolk B, et al. When it comes to snakebites, kids are little adults: a comparison of adults and children with rattlesnake bites. J Med Toxicol. 2020;16(4):444–451. doi: 10.1007/s13181-020-00776-6.
  • Zdenek CN, Rodrigues CFB, Bourke LA, et al. Children and snakebite: snake venom effects on adult and paediatric plasma. Toxins (Basel). 2023;15(2):158. doi: 10.3390/toxins15020158.
  • Dart RC, Hurlbut KM, Garcia R, et al. Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med. 1996;27(3):321–326. doi: 10.1016/s0196-0644(96)70267-6.
  • Isbister GK. Snakebite doesn’t cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost. 2010;36(4):444–451. doi: 10.1055/s-0030-1254053.
  • Park KH, Shin H, Kang H, et al. Effectiveness of repeated antivenom therapy for snakebite-related systemic complications. J Int Med Res. 2019;47(10):4808–4814. doi: 10.1177/0300060519870012.
  • Kumar KS, Narayanan S, Udayabhaskaran V, et al. Clinical and epidemiologic profile and predictors of outcome of poisonous snake bites - an analysis of 1,500 cases from a tertiary care center in malabar, North Kerala, India. Int J Gen Med. 2018;11:209–216. doi: 10.2147/IJGM.S136153.
  • Tavares AV, Araujo KAM, Marques MRV, et al. The epidemiology of snakebite in the Rio Grande Do Norte state. Northeastern Brazil. Rev Inst Med Trop Sao Paulo. 2017;59:e52.
  • Liang Q, Huynh TM, Konstantakopoulos N, et al. An examination of the neutralization of in vitro toxicity of chinese cobra (naja atra) venom by different antivenoms. Biomedicines. 2020;8(10):377. doi: 10.3390/biomedicines8100377.
  • Fung HT, Yung WH, Crow P, et al. Green pit viper antivenom from Thailand and agkistrodon halys antivenom from China compared in treating cryptelytrops albolabris envenomation of mice. Hong Kong Med J. 2012;18:40–45.
  • World Health Organization. In Guidelines for the management of snakebites. 1st ed. New Delhi (India): WHO Regional Office for South-East Asia; 2010.
  • Li QQ, Zeng LB, Deng HY, et al. Adverse reactions to four types of monovalent antivenom used in the treatment of snakebite envenoming in South China. Toxicon. 2022;219:106935. doi: 10.1016/j.toxicon.2022.106935.
  • Zeng LB, Liang Q, Liang ZJ, et al. Effectiveness of clotting factor replacement therapy after antivenom treatment on coagulopathic envenomation following green pit viper bites: a retrospective observational study. BMC Emerg Med. 2022;22(1):9. doi: 10.1186/s12873-022-00569-w.
  • Mitrakul C. Effects of green pit viper (Trimeresurus erythrurus and Trimeresurus popeorum) venoms on blood coagulation, platelets and the fibrinolytic enzyme systems: studies in vivo and in vitro. Am J Clin Pathol. 1973;60(5):654–662. doi: 10.1093/ajcp/60.5.654.
  • White J. Snake venoms and coagulopathy. Toxicon. 2005;45(8):951–967. doi: 10.1016/j.toxicon.2005.02.030.
  • Othong R, Eurcherdkul T, Chantawatsharakorn P. Green pit viper envenomations in bangkok: a comparison of follow-up compliance and clinical outcomes in older and younger adults. Toxins (Basel). 2022;14(12):869. doi: 10.3390/toxins14120869.
  • Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18–35. doi: 10.1038/ajg.2016.517.
  • Thumtecho S, Tangtrongchitr T, Srisuma S, et al. Haematotoxic manifestations and management of green pit viper bites in Thailand. Ther Clin Risk Manag. 2020;16:695–704. doi: 10.2147/TCRM.S261303.
  • Isbister GK, Duffull SB, Brown SG. Failure of antivenom to improve recovery in Australian snakebite coagulopathy. QJM. 2009;102(8):563–568. doi: 10.1093/qjmed/hcp081.
  • Brown SG, Caruso N, Borland ML, et al. Clotting factor replacement and recovery from snake venom-induced consumptive coagulopathy. Intensive Care Med. 2009;35(9):1532–1538. doi: 10.1007/s00134-009-1556-7.
  • Isbister GK, Jayamanne S, Mohamed F, et al. A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell’s viper (daboia russelii) envenoming. J Thromb Haemost. 2017;15(4):645–654. doi: 10.1111/jth.13628.
  • Claudet I, Maréchal C, Gurrera E, et al. Risk factors for high-grade envenomations after French viper bites in children. Pediatr Emerg Care. 2012;28(7):650–654. doi: 10.1097/PEC.0b013e31825cfd66.
  • Marano M, Pisani M, Stoppa F, et al. Antitoxin use and peadiatric intensive care for viper bites in Rome, Italy. Eur Rev Med Pharmacol Sci. 2014;18(4):485–492.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.